
Thursday, July 01, 2021 12:29:18 PM

Liked By
Spread the love. Be the first to like this post!
Recent IPSC News
- Century Therapeutics to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 02/01/2023 12:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/09/2023 12:02:16 PM
- Century Therapeutics Announces Internal Portfolio Prioritization to Extend Cash Runway Into 2026 • GlobeNewswire Inc. • 01/05/2023 09:01:00 PM
- Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/04/2023 12:00:00 PM
- Century Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference • GlobeNewswire Inc. • 11/22/2022 12:00:00 PM
- Century Therapeutics Announces Presentation of Preclinical Data at the SITC 37th Annual Meeting and Provides Pipeline Updates • GlobeNewswire Inc. • 11/11/2022 12:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/10/2022 10:19:05 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/10/2022 12:32:52 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/10/2022 12:32:06 PM
- Century Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/10/2022 12:30:00 PM
- Century Therapeutics to Host Virtual Research and Development Day on November 11, 2022 • GlobeNewswire Inc. • 11/02/2022 11:05:00 AM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 10/11/2022 06:10:29 PM
- Century Therapeutics to Present at the SITC 37th Annual Meeting • GlobeNewswire Inc. • 10/05/2022 08:05:00 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 10/03/2022 08:09:15 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 10/03/2022 08:05:25 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 10/03/2022 11:10:02 AM
- Century Therapeutics Announces Appointment of Daphne Quimi and Timothy Walbert to its Board of Directors • GlobeNewswire Inc. • 10/03/2022 11:00:00 AM
- Century Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference • GlobeNewswire Inc. • 09/26/2022 11:00:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 09/08/2022 11:32:14 AM
- Century Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference • GlobeNewswire Inc. • 09/06/2022 11:00:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 08/25/2022 11:47:14 AM
- Century Therapeutics Receives Study May Proceed Notification from FDA for CNTY-101, the First Allogeneic Cell Therapy Product Candidate Engineered to Overcome Three Major Pathways of Host vs Graft Rejection • GlobeNewswire Inc. • 08/25/2022 11:30:00 AM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 08/11/2022 08:56:39 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 08/11/2022 12:01:24 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 08/11/2022 11:33:08 AM
TNRG Files A Reg A Offering, To Raise $75 million • TNRG • Feb 1, 2023 10:07 AM
IQST - iQSTEL Announces Board Election and CPA Ratification Following Annual Shareholder Meeting • IQST • Feb 1, 2023 10:04 AM
1606 Corp. (OTC | CBDW) to Produce a New Inventory of CBD Smokables to Supply an Additional 2500 Retail Outlets, Engages Direct Marketing Expert to Head Efforts • CBDW • Feb 1, 2023 8:30 AM
ITRONICS RECEIVES VALUATION REPORT FOR ITS INTELLECTUAL PROPERTY TO OBTAIN NON-DILUTIVE FINANCING • ITRO • Feb 1, 2023 6:30 AM
Kona Gold Beverage, Inc Announces Distribution Agreement with Norman Distribution in Illinois • KGKG • Jan 31, 2023 9:00 AM
PSYC Provides Shareholders with Key Corporate Updates and Highlights Objectives for 2023 • PSYC • Jan 31, 2023 8:30 AM